A team of German scientists believe that they have worked out why some people given the AstraZeneca and Johnson & Johnson vaccines against Covid-19 develop blood clots – and claim they can tell the manufacturers how to improve the vaccine to avoid it.
The key is in the adenovirus – the common cold virus that is used to deliver the spike protein of the coronavirus into the body, say Rolf Marschalek, a professor at Goethe university in Frankfurt, and colleagues. The mRNA vaccines developed by Pfizer/BioNTech and Moderna do not use this delivery system and there have been no blood clotting cases linked to them.
The blood clots are rare but troubling in the younger age group who are more at risk of clotting and less likely to experience severe Covid illness. The UK is now offering anyone under the age of 40 a choice of vaccines, where available. There have been 309 cases in the UK out of 33 million people given the AstraZeneca vaccine.
The scientists in a pre-print which has not undergone peer review say they believe the problem lies in the entry of the adenovirus into the nucleus of the cell rather than the just the cellular fluid, where the virus normally makes proteins.
“The adenovirus life cycle includes the infection of cells … entry of the adenoviral DNA into the nucleus, and subsequently gene transcription by the host transcription machinery,” they write.
“And exactly here lies the problem: the viral piece of DNA … is not optimised to be transcribed inside of the nucleus.”
Inside the cell nucleus, parts of the spike protein splice or split apart. These become mutant protein pieces which float off into the body and can very rarely trigger blood clots, the scientists believe.
Prof Marschalek says the vaccines can be redesigned to avoid the problem.
Modern Approaches to Augmentation of Brain Function Available from Springer Press This book covers recent advances in neural technology that provide for enhancements for brain function. It addresses a broad range of neural phenomena [...]
Although the currently available COVID-19 vaccines are highly effective, limited manufacturing capacity and the need for cold-chain storage hinder their global distribution. A recent study tested the efficacy of a new adeno-associated virus (AAV) [...]
Fully vaccinated people were 11 times less likely to die of COVID and 10 times less likely to be hospitalized compared to the unvaccinated since highly contagious Delta became the most common variant, US [...]
The highly-infectious Delta coronavirus variant has spread to at least 174 countries worldwide, from the US to Australia, causing a surge in COVID-19 cases. The variant has mutations that help it partially escape the immune response produced by [...]
Fragile mRNA molecules used in COVID-19 vaccines can’t get into cells on their own. They owe their success to lipid nanoparticles that took decades to refine. Messenger RNA (mRNA) is having a moment. This [...]
The COVID-19 pandemic has revealed critical knowledge gaps and assumptions concerning how respiratory viruses spread between hosts. Traditionally thought to be spread mainly through large respiratory droplets produced by the coughs and sneezes of sick individuals, [...]
SARS-CoV-2 is just one of nonillions of viruses on our planet, and scientists are rapidly identifying legions of new species. Mya Breitbart has hunted novel viruses in African termite mounds, Antarctic seals and water [...]
As a team of South African researchers we have identified a new lineage of SARS-CoV-2, the virus causing COVID-19. A lineage represents a genetically distinct virus population with a common ancestor. This virus may be designated as a variant [...]
Citing the possibility of another serious pandemic, the Biden administration on Friday laid out a plan to transform the nation’s ability to respond to major biological threats. As staggering as the COVID-19 pandemic has been, [...]
How doctors can predict which patients are more likely to die of COVID Several studies have come out about the COVID prognosis. As a result, we now have a powerful way to predict [...]
Though Delta continues to be the dominant COVID-19 strain, the World Health Organization (WHO) now says there's a new variant to keep your eye on. The B.1.621 variant, also called Mu, has just been [...]
Being fully vaccinated against Covid-19 not only cuts the risk of catching it, but also of an infection turning into long Covid, research led by King's College London suggests. It shows that in the [...]
Moderna Inc.’s Covid vaccine generated more than double the antibodies of a similar shot made by Pfizer Inc. and BioNTech SE in research directly comparing immune responses to the inoculations. A study of almost [...]
A coronavirus variant first detected in South Africa 'could be more infectious' than other mutations and have the potential to 'evade vaccines', scientists have said. The C.1.2 strain, which is linked to 'increased transmissibility', is more mutations away from [...]